Cargando…

HDAC6 inhibitor WT161 induces apoptosis in retinoblastoma cells and synergistically interacts with cisplatin

BACKGROUND: WT161 is a recently discovered histone deacetylase 6 (HDAC6) inhibitor which shows anti-tumor effects on multiple myelomas and breast cancer. However, the role of WT161 in retinoblastoma remains unclear. The aim of this study is to explore the role of WT161 in retinoblastoma and its unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jun, Qian, Xia, Zhang, Feifei, Tang, Xiaofeng, Ju, Cheng, Liu, Renfeng, Zhou, Ruihao, Zhang, Zhiping, Lv, Xiao-Bin, Zhang, Changhua, Huang, Guofu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798655/ https://www.ncbi.nlm.nih.gov/pubmed/35117033 http://dx.doi.org/10.21037/tcr.2019.10.30

Ejemplares similares

HDAC6 inhibitor WT161 performs anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
por: Sun, Jun, et al.
Publicado: (2021)

The synergistic anticancer effect of the bromodomain inhibitor OTX015 and histone deacetylase 6 inhibitor WT-161 in osteosarcoma
por: Yu, Bo, et al.
Publicado: (2022)

HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
por: Hideshima, Teru, et al.
Publicado: (2017)

Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer
por: Hideshima, Teru, et al.
Publicado: (2021)

Targeting the ‘garbage-bin’ to fight cancer: HDAC6 inhibitor WT161 has an anti-tumor effect on osteosarcoma and synergistically interacts with 5-FU
por: Sergi, Consolato M.
Publicado: (2021)

The HDAC Inhibitor, SAHA, Combined with Cisplatin Synergistically Induces Apoptosis in Alpha-fetoprotein-producing Hepatoid Adenocarcinoma Cells
por: Kyaw, Myat Tin Htwe, et al.
Publicado: (2019)

Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma
por: Zhou, Ruihao, et al.
Publicado: (2020)

Regulation of retinoic acid synthetic enzymes by WT1 and HDAC inhibitors in 293 cells
por: Li, Yifan, et al.
Publicado: (2017)

AB161. Rottlerin-induced autophagy leads to the apoptosis in bladder cancer cells
por: Qi, Ping, et al.
Publicado: (2016)

The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis
por: Wang, Tsz Ki, et al.
Publicado: (2023)

WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1
por: Lv, Long, et al.
Publicado: (2015)

Exosomes May Be the Potential New Direction of Research in Osteoarthritis Management
por: Ju, Cheng, et al.
Publicado: (2019)

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
por: Heinemann, Anja, et al.
Publicado: (2015)

miR-512-3p Overcomes Resistance to Cisplatin in Retinoblastoma by Promoting Apoptosis Induced by Endoplasmic Reticulum Stress
por: Kong, Miao, et al.
Publicado: (2020)

HDAC6 Inhibition Protects against OGDR-Induced Golgi Fragmentation and Apoptosis
por: Zhang, Jie, et al.
Publicado: (2019)

Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines
por: Busch, Maike, et al.
Publicado: (2018)

LncRNA SNHG5 promotes the progression of osteosarcoma by sponging the miR-212-3p/SGK3 axis
por: Ju, Cheng, et al.
Publicado: (2018)

Functional genomics identifies new synergistic therapies for retinoblastoma
por: Aubry, Arthur, et al.
Publicado: (2020)

Synergistic effect of HDAC inhibitor Chidamide with Cladribine on cell cycle arrest and apoptosis by targeting HDAC2/c-Myc/RCC1 axis in acute myeloid leukemia
por: Gu, Siyu, et al.
Publicado: (2023)

Osr1 Interacts Synergistically with Wt1 to Regulate Kidney Organogenesis
por: Xu, Jingyue, et al.
Publicado: (2016)

Concomitant epigenetic targeting of LSD1 and HDAC synergistically induces mitochondrial apoptosis in rhabdomyosarcoma cells
por: Haydn, Tinka, et al.
Publicado: (2017)

Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
por: Wang, Lei, et al.
Publicado: (2012)

The decade of exosomal long RNA species: an emerging cancer antagonist
por: Zhou, Ruihao, et al.
Publicado: (2018)

Synergistic Interactions between HDAC and Sirtuin Inhibitors in Human Leukemia Cells
por: Cea, Michele, et al.
Publicado: (2011)

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
por: Zuco, Valentina, et al.
Publicado: (2011)

Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
por: Lobo, João, et al.
Publicado: (2020)

The HDAC Inhibitor Quisinostat (JNJ-26481585) Supresses Hepatocellular Carcinoma alone and Synergistically in Combination with Sorafenib by G0/G1 phase arrest and Apoptosis induction
por: He, Bin, et al.
Publicado: (2018)

Synergistic killing of lung cancer cells by cisplatin and radiation via autophagy and apoptosis
por: LIU, MIN, et al.
Publicado: (2014)

The Synergistic Combination of Cisplatin and Piperine Induces Apoptosis in MCF-7 Cell Line
por: Fattah, Abolfazl, et al.
Publicado: (2021)

Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN
por: Zhang, Guanhua, et al.
Publicado: (2017)

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1
por: Beyer, Mandy, et al.
Publicado: (2019)

Multimodal imaging and photothermal synergistic immunotherapy of retinoblastoma with tuftsin-loaded carbonized MOF nanoparticles
por: Zou, Hongmi, et al.
Publicado: (2022)

Effects of matrine on the proliferation and apoptosis of vincristine-resistant retinoblastoma cells
por: Zhao, Bowen, et al.
Publicado: (2020)

Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
por: Hontecillas-Prieto, Lourdes, et al.
Publicado: (2020)

Selective HDAC6 inhibitor TubA offers neuroprotection after intracerebral hemorrhage via inhibiting neuronal apoptosis
por: Peng, Cuiying, et al.
Publicado: (2023)

The synergistic anticancer effect of cisplatin combined with Oldenlandia diffusa in osteosarcoma MG-63 cell line in vitro
por: Pu, Feifei, et al.
Publicado: (2016)

A simple and automated method for (161)Tb purification and ICP-MS analysis of (161)Tb
por: McNeil, Scott W., et al.
Publicado: (2022)

Sulfated polymannuroguluronate TGC161 ameliorates leukopenia by inhibiting CD4(+) T cell apoptosis
por: Shi, Chuanqin, et al.
Publicado: (2020)

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors
por: Rodrigues Moita, Ana J., et al.
Publicado: (2020)

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
por: Hölscher, Alexander S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qk9i9g373g7md35jq733h749ro